DexCom, Inc. Innovation and Growth Catalysts Amid Strong Long-Term Outlook for Diabetes Care
| DXCM Stock | USD 77.77 0.23 0.29% |
About 62% of DexCom's investor base is looking to short. The analysis of overall sentiment of trading DexCom Inc stock suggests that many investors are alarmed at this time. DexCom's investing sentiment overview a quick insight into current market opportunities from investing in DexCom Inc. Many technical investors use DexCom Inc stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
DexCom |
We recently compiled a list of the Wells Fargo
Read at insidermonkey.com
 |
DexCom Fundamental Analysis
We analyze DexCom's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of DexCom using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of DexCom based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Short Ratio
Short Ratio Comparative Analysis
DexCom is currently under evaluation in short ratio category among its peers. Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
DexCom Inc Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with DexCom stock to make a market-neutral strategy. Peer analysis of DexCom could also be used in its relative valuation, which is a method of valuing DexCom by comparing valuation metrics with similar companies.
Peers
DexCom Related Equities
| IART | Integra LifeSciences | 0.93 | ||||
| MDT | Medtronic PLC | 0.43 | ||||
| INMD | InMode | 0.42 | ||||
| INSP | Inspire Medical | 0.40 | ||||
| ABT | Abbott Laboratories | 0.29 | ||||
| ZBH | Zimmer Biomet | 0.22 | ||||
| BSX | Boston Scientific | 0.07 | ||||
| EW | Edwards Lifesciences | 0.28 | ||||
| PEN | Penumbra | 0.29 | ||||
| TNDM | Tandem Diabetes | 0.50 | ||||
| PODD | Insulet | 1.62 | ||||
| SENS | Senseonics Holdings | 9.62 |
Check out DexCom Hype Analysis, DexCom Correlation and DexCom Performance. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Is Medical Equipment space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DexCom. If investors know DexCom will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DexCom listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of DexCom Inc is measured differently than its book value, which is the value of DexCom that is recorded on the company's balance sheet. Investors also form their own opinion of DexCom's value that differs from its market value or its book value, called intrinsic value, which is DexCom's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DexCom's market value can be influenced by many factors that don't directly affect DexCom's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DexCom's value and its price as these two are different measures arrived at by different means. Investors typically determine if DexCom is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DexCom's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.